Vivos (RDGL) Common Equity (2010 - 2025)
Vivos recorded quarterly Common Equity of $1.7 million in Q4 2025, down 23.9% quarter-over-quarter from $2.2 million in Q3 2025, and down 22.65% year-over-year from $2.1 million in Q4 2024.
Vivos' Common Equity history runs 16 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- In Q4 2025, Common Equity fell 22.65% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 22.65% YoY), while the FY2025 annual figure was $1.7 million, down 22.65% from the prior year.
- Common Equity came in at $1.7 million for Q4 2025 at Vivos, down from $2.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $3.2 million in Q1 2025 to a low of $893020.0 in Q2 2022.
- A 5-year average of $1.7 million and a median of $1.6 million in 2021 frame the typical range for Common Equity.
- Across the five-year window, Common Equity soared 4480.7% in 2021 and slumped 45.06% in 2022, its largest moves.
- Vivos' Common Equity stood at $1.5 million in 2021, then advanced by 13.2% to $1.7 million in 2022, then decreased by 17.82% to $1.4 million in 2023, then jumped by 57.29% to $2.1 million in 2024, then retreated by 22.65% to $1.7 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered $1.7 million, $2.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Vivos | - | - | -3,105.00 | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 893,020.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.63 Mn |
| Mar 31, 2021 | 1.83 Mn |
| Dec 31, 2020 | 32,034.00 |
| Sep 30, 2020 | -870,233.00 |
| Jun 30, 2020 | -784,642.00 |
| Mar 31, 2020 | -1.25 Mn |
| Dec 31, 2019 | -1.48 Mn |
| Sep 30, 2019 | -1.19 Mn |
| Jun 30, 2019 | -1.23 Mn |
| Mar 31, 2019 | -1.05 Mn |
| Dec 31, 2018 | -942,174.00 |
| Sep 30, 2018 | -34.70 Mn |
| Jun 30, 2018 | -10.67 Mn |
| Mar 31, 2018 | -5.09 Mn |
| Dec 31, 2017 | -4.26 Mn |
| Sep 30, 2017 | -3.54 Mn |
| Jun 30, 2017 | -15.14 Mn |
| Mar 31, 2017 | -14.95 Mn |
| Dec 31, 2016 | -3.02 Mn |
| Sep 30, 2016 | -21.94 Mn |
| Jun 30, 2016 | -22.80 Mn |
| Mar 31, 2016 | -19.69 Mn |
| Dec 31, 2015 | -14.33 Mn |
| Sep 30, 2015 | -8.77 Mn |
| Jun 30, 2015 | -15.58 Mn |
| Mar 31, 2015 | -21.17 Mn |
| Dec 31, 2014 | -20.16 Mn |
| Sep 30, 2014 | -9.44 Mn |
| Jun 30, 2014 | -9.67 Mn |
| Mar 31, 2014 | -9.34 Mn |
| Dec 31, 2013 | -8.97 Mn |
| Sep 30, 2013 | -8.48 Mn |
| Jun 30, 2013 | -8.07 Mn |
| Mar 31, 2013 | -8.28 Mn |
| Dec 31, 2012 | -9.85 Mn |
| Sep 30, 2012 | -5.88 Mn |
| Jun 30, 2012 | -6.20 Mn |
| Mar 31, 2012 | -5.47 Mn |
| Dec 31, 2011 | -4.84 Mn |
| Sep 30, 2011 | -4.19 Mn |
| Jun 30, 2011 | -3.91 Mn |
| Dec 31, 2010 | -2.96 Mn |